Kotridis, Panagiotis <br/><br/>
Plasma atrial natriuretic peptide in essential hypertension after treatment with irbesartan.  [electronic resource] 

 -  Blood pressure  2002 
 - 91-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0803-7051 
<br/><br/><label>Standard No.: </label>10.1080/08037050211263  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiotensin Receptor Antagonists<br/>Antihypertensive Agents--therapeutic use<br/>Atrial Natriuretic Factor--blood<br/>Biphenyl Compounds--therapeutic use<br/>Blood Pressure--drug effects<br/>Humans<br/>Hypertension--blood<br/>Irbesartan<br/>Male<br/>Middle Aged<br/>Receptor, Angiotensin, Type 1<br/>Tetrazoles--therapeutic use